Citalopram decreases agitation in the context of Alzheimer's disease, but at doses higher than those commonly prescribed and at the expense of side effects.
Cambridge and Peterborough NHS Foundation Trust, Cambridge, UK;
Benjamin R
BR
Underwood
University of East Anglia, Norwich, UK.
Chris
C
Fox
D000544:Alzheimer Disease / Q000150:complications*; D015283:Citalopram / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011595:Psychomotor Agitation / Q000188:drug therapy* / Q000209:etiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors
Accident & Emergency Medicine